(TROW) T. Rowe Price - Overview
Stock: Mutual Funds, Retirement Plans, Asset Management, Advisory Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.21% |
| Yield on Cost 5y | 3.87% |
| Yield CAGR 5y | -8.73% |
| Payout Consistency | 91.9% |
| Payout Ratio | 52.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.4% |
| Relative Tail Risk | -3.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -28.00 |
| Character TTM | |
|---|---|
| Beta | 1.202 |
| Beta Downside | 1.029 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.05% |
| CAGR/Max DD | -0.08 |
Description: TROW T. Rowe Price December 19, 2025
T. Rowe Price Group, Inc. (NASDAQ:TROW) is a publicly traded, globally diversified investment manager that offers equity and fixed-income mutual funds to individuals, retirement plans, financial intermediaries, and institutional clients. The firm employs a bottom-up investment process that blends fundamental and quantitative analysis, leverages both internal and external research, and incorporates ESG considerations across its portfolios. It also participates in late-stage venture capital deals, typically committing $3-5 million per transaction.
As of the most recent quarter, T. Rowe Price reported assets under management (AUM) of roughly $1.5 trillion, with net inflows of $12 billion driven largely by strong demand for actively managed fixed-income products amid a volatile interest-rate environment. The company’s revenue growth is closely tied to fee-based income, which benefits from a secular shift toward higher-margin advisory services, while fee compression from passive alternatives remains a sector-wide headwind. Additionally, the firm’s operating margin has stabilized near 30 % after cost-efficiency initiatives launched in 2022.
For a deeper quantitative assessment, you may want to explore ValueRay’s analyst tools to evaluate TROW’s valuation and risk profile.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 2.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.08 > 1.0 |
| NWC/Revenue: 40.77% < 20% (prev 43.51%; Δ -2.75% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.49b > Net Income 2.09b |
| Net Debt (-3.38b) to EBITDA (2.88b): -1.17 < 3 |
| Current Ratio: 8.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.8m) vs 12m ago 0.43% < -2% |
| Gross Margin: 62.67% > 18% (prev 0.52%; Δ 6215 % > 0.5%) |
| Asset Turnover: 52.60% > 50% (prev 52.65%; Δ -0.06% > 0%) |
| Interest Coverage Ratio: -5.70 > 6 (EBITDA TTM 2.88b / Interest Expense TTM -429.4m) |
Altman Z'' 8.28
| A: 0.21 (Total Current Assets 3.38b - Total Current Liabilities 396.2m) / Total Assets 14.34b |
| B: 0.75 (Retained Earnings 10.82b / Total Assets 14.34b) |
| C: 0.18 (EBIT TTM 2.45b / Avg Total Assets 13.91b) |
| D: 3.12 (Book Value of Equity 10.86b / Total Liabilities 3.48b) |
| Altman-Z'' Score: 8.28 = AAA |
What is the price of TROW shares?
Over the past week, the price has changed by -10.50%, over one month by -13.24%, over three months by -6.28% and over the past year by -10.63%.
Is TROW a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 9
- Sell: 4
- StrongSell: 0
What are the forecasts/targets for the TROW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 103.3 | 9.2% |
| Analysts Target Price | 103.3 | 9.2% |
| ValueRay Target Price | 97 | 2.5% |
TROW Fundamental Data Overview February 07, 2026
P/E Forward = 9.5238
P/S = 2.75
P/B = 1.9496
P/EG = 4.5339
Revenue TTM = 7.31b USD
EBIT TTM = 2.45b USD
EBITDA TTM = 2.88b USD
Long Term Debt = unknown (none)
Short Term Debt = 455.1m USD (from shortTermDebt, two quarters ago)
Debt = 455.1m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -3.38b USD (from netDebt column, last quarter)
Enterprise Value = 17.19b USD (20.12b + Debt 455.1m - CCE 3.38b)
Interest Coverage Ratio = -5.70 (Ebit TTM 2.45b / Interest Expense TTM -429.4m)
EV/FCF = 11.30x (Enterprise Value 17.19b / FCF TTM 1.52b)
FCF Yield = 8.85% (FCF TTM 1.52b / Enterprise Value 17.19b)
FCF Margin = 20.80% (FCF TTM 1.52b / Revenue TTM 7.31b)
Net Margin = 28.53% (Net Income TTM 2.09b / Revenue TTM 7.31b)
Gross Margin = 62.67% ((Revenue TTM 7.31b - Cost of Revenue TTM 2.73b) / Revenue TTM)
Gross Margin QoQ = 94.57% (prev 53.06%)
Tobins Q-Ratio = 1.20 (Enterprise Value 17.19b / Total Assets 14.34b)
Interest Expense / Debt = 249.5% (Interest Expense 1.14b / Debt 455.1m)
Taxrate = 27.37% (167.8m / 613.1m)
NOPAT = 1.78b (EBIT 2.45b * (1 - 27.37%))
Current Ratio = 8.53 (Total Current Assets 3.38b / Total Current Liabilities 396.2m)
Debt / Equity = 0.04 (Debt 455.1m / totalStockholderEquity, last quarter 10.86b)
Debt / EBITDA = -1.17 (Net Debt -3.38b / EBITDA 2.88b)
Debt / FCF = -2.22 (Net Debt -3.38b / FCF TTM 1.52b)
Total Stockholder Equity = 10.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.01% (Net Income 2.09b / Total Assets 14.34b)
RoE = 19.58% (Net Income TTM 2.09b / Total Stockholder Equity 10.66b)
RoCE = 17.54% (EBIT 2.45b / Capital Employed (Total Assets 14.34b - Current Liab 396.2m))
RoIC = 16.78% (NOPAT 1.78b / Invested Capital 10.59b)
WACC = 10.11% (E(20.12b)/V(20.57b) * Re(10.34%) + (debt cost/tax rate unavailable))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF Debug] Terminal Value 67.42% ; FCFF base≈1.48b ; Y1≈1.25b ; Y5≈946.3m
Fair Price DCF = 72.06 (EV 12.37b - Net Debt -3.38b = Equity 15.75b / Shares 218.6m; r=10.11% [WACC]; 5y FCF grow -18.74% → 2.90% )
EPS Correlation: 50.04 | EPS CAGR: -1.88% | SUE: -0.10 | # QB: 0
Revenue Correlation: 68.05 | Revenue CAGR: 1.00% | SUE: -2.30 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.42 | Chg30d=-0.107 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-12-31): EPS=10.08 | Chg30d=-0.236 | Revisions Net=+2 | Growth EPS=+3.8% | Growth Revenue=+3.8%
EPS next Year (2027-12-31): EPS=10.27 | Chg30d=-0.104 | Revisions Net=+1 | Growth EPS=+1.8% | Growth Revenue=+2.4%